EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Outcomes of Limited Resection for Tumours Greater Than 20 mm in Non-Small Cell Lung Cancer

Shigeki Suzuki, Keisuke Asakura iD, Kyohei Masai iD, Kaoru Kaseda, Tomoyuki Hishida iD, Akio Kazama, Takao Shigenobu, Ryutaro Hanawa, Katsura Emoto iD, Yasunori Sato

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf322 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Shigeki Suzuki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Thoracic Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonectomy. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Covidien Japan, Daiichi-Sankyo Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Sublobar resection is an established surgical option for early-stage non-small cell lung cancer. However, evidence remains limited regarding its use for tumours >20 mm in real-world settings. We evaluated characteristics and outcomes of limited resection in this context and identified predictors of local recurrence. METHODS We retrospectively analysed 165 patients with clinical stage I non-small cell lung cancer with tumours >20 mm who underwent limited resection between 2007 and 2017. Clinical, pathological, and radiological data were reviewed. The primary end-point was local recurrence, assessed using competing risk analysis. Overall survival and disease-free survival were estimated using Kaplan-Meier and Cox models. RESULTS We analysed 165 patients with 13 local recurrence events. Among them, 146 (88.5%) had identifiable reasons for not undergoing lobectomy. Segmentectomy and wedge resection were performed in 59% and 41% of cases, respectively. Lymph node dissection was performed in all segmentectomies and in 20% of wedge resections. The 5-year overall and disease-free survival rates were 64.0% and 62.1%. Local recurrence occurred in 8%, more frequently after wedge resection than segmentectomy (13% vs 4%, P = .04). Solid-predominant tumours with a consolidation-to-tumour ratio greater than 0.5 accounted for 76% and were independently associated with lower disease-free survival (hazard ratio, 2.65; P = .05) and higher local recurrence (hazard ratio: infinite; P < .001). No local recurrence was observed in tumours with a ground-glass opacity-predominant pattern. CONCLUSIONS Limited resection showed acceptable outcomes in lung cancers >20 mm, especially with ground-glass opacity; solid-predominant CT patterns were strongly linked to recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPneumonectomyHumansMaleFemaleRetrospective StudiesAgedMiddle AgedNeoplasm Recurrence, LocalTreatment OutcomeNeoplasm StagingAged, 80 and overDisease-Free Survival

Stichwörter der Autor:innen

consolidation-to-tumour ratiolocal recurrencenon-small cell lung cancerpassive limited resectionsurgical margin

Autor:innen und Institutionen

  • Department of General Thoracic Surgery, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Department of General Thoracic Surgery, Sagamihara Kyodo Hospital, Kanagawa 252-5188, Japan.
  • Department of Pathology, Sagamihara Kyodo Hospital, Kanagawa 252-5188, Japan.
  • Department of General Thoracic Surgery, Saiseikai Utsunomiya Hospital, Tochigi 321-0974, Japan.
  • Department of Pathology, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Department of Biostatistics, Keio University School of Medicine, Tokyo 160-8582, Japan.

ORCID-Profile: Keisuke Asakura, Kyohei Masai, Tomoyuki Hishida, Katsura Emoto

Förderung

  • Covidien Japan
  • Daiichi-Sankyo Company

Zitieren

APA

Suzuki, S., Asakura, K., Masai, K., Kaseda, K., Hishida, T., Kazama, A., Shigenobu, T., Hanawa, R., Emoto, K., & Sato, Y. (2025). Real-World Outcomes of Limited Resection for Tumours Greater Than 20 mm in Non-Small Cell Lung Cancer. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf322

Vancouver

Suzuki S, Asakura K, Masai K, Kaseda K, Hishida T, Kazama A, et al. Real-World Outcomes of Limited Resection for Tumours Greater Than 20 mm in Non-Small Cell Lung Cancer. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf322

BibTeX
@article{Suzuki2025,
  author = {Suzuki, Shigeki and Asakura, Keisuke and Masai, Kyohei and Kaseda, Kaoru and Hishida, Tomoyuki and Kazama, Akio and Shigenobu, Takao and Hanawa, Ryutaro and Emoto, Katsura and Sato, Yasunori},
  title = {Real-World Outcomes of Limited Resection for Tumours Greater Than 20 mm in Non-Small Cell Lung Cancer},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf322}
}
Kostenlos starten →